ExL’s 3rd Quality Oversight of Clinical Vendors Conference, taking place October 22-24 at the Westin Alexandria, provides strategies for assessing and managing quality at CROs and other clinical providers. Attracting a loyal audience of both senior-level clinical quality and clinical operations executives from mostly pharma, biotech and medical device companies, this unique event offers a highly interactive forum where participants candidly share both positive and negative experiences resulting in an honest and educational exchange of lessons learned and best practices. Leave the event with an accurate benchmark of how your company’s oversight strategies compare to others and practical improvement methodologies to streamline and optimize quality oversight operations.
- Benchmark your clinical quality oversight operations against others in the industry at this honest and candid exchange of best practices and lessons learned.
- Hear industry experts from both clinical quality and clinical operations share case study presentations providing you with practical take-away information to improve, streamline and optimize your clinical oversight strategy.
Esther Timmeney, Compliance Advice and Assurance Advisor, AstraZeneca
"The conference and speakers were all excellent. This was a very valuable conference and input from the participants will improve our quality oversight of vendors."
Brandy Schenck, Auditor, Quality Assurance, Infinity Pharmaceuticals
"This was one of the best I’ve attended in a long while. Interactions were excellent."
Grace Crawford, Senior Director, QA, ICON
"Excellent. Well worth the time attending. Great representation from industry for speakers—not the same old crowd."
Linda Donahoe, Director, Genzyme
"Conference was a positive open forum that provided an opportunity for sponsors and vendors to come together and share experiences, lessons learned, and identify a path to improve sponsor oversight through better channels of communication."
Maryann Livolsi, Associate Director, Global R&D Quality Assurance,Shire Pharmaceuticals
"Exceeded expectations. Excellent conference with excellent speakers. All of us learned a lot and conferences like these are what improve the drug development process.."
Munish Mehra, PhD, Managing Director, Global Drug Development Experts
"This seminar was one of the best I have attended."
Joan Millsaps,Director, Business Operations & Outsourcing Management,Bristol-Myers Squibb Corporation
Who Should Attend
C-Level, Vice President, Director & Manager level executives from the following departments at Pharma/Biotech companies, CROs and other clinical trial service providers:
- Clinical Quality Assurance/ QA
- Clinical Quality Control/ QC
- Clinical Oversight
- Vendor Management
- Quality Management
- Clinical Operations/Development/Affairs including
- Clinical Trial Managers
- Clinical Trial Monitors
- Project Managers
- CRAs
- Clinical Outsourcing/Contracts
- Compliance/Global Compliance
- Drug Safety & Risk Management/Operations
- Good Clinical Practice/ GCP
- Global QA/Compliance
- Regulatory Affairs
